| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Antoine Dufour | Q91487804 |
| P2093 | author name string | Daniel Young | |
| Nabangshu Das | |||
| Anthonia Anowai | |||
| P2860 | cites work | Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration | Q41913259 |
| Platelet matrix metalloprotease-1 mediates thrombogenesis by activating PAR1 at a cryptic ligand site | Q42177034 | ||
| The first MMP in sepsis | Q42233338 | ||
| Ephrin-B2-induced cleavage of EphB2 receptor is mediated by matrix metalloproteinases to trigger cell repulsion | Q42264802 | ||
| ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site | Q42382724 | ||
| EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. | Q42795950 | ||
| Similarities and differences in the way transmembrane-type ligands interact with the Elk subclass of Eph receptors. | Q42818095 | ||
| Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase | Q43559838 | ||
| An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase | Q43821714 | ||
| Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. | Q43945272 | ||
| Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells | Q45023433 | ||
| Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis. | Q46260965 | ||
| Pervanadate-induced shedding of the intercellular adhesion molecule (ICAM)-1 ectodomain is mediated by membrane type-1 matrix metalloproteinase (MT1-MMP). | Q46613828 | ||
| Trends in GPCR drug discovery: new agents, targets and indications. | Q47597808 | ||
| Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells | Q47784861 | ||
| Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy | Q47891881 | ||
| Structure and dynamics of GPCR signaling complexes. | Q50093625 | ||
| Ablation of matrix metalloproteinase-9 increases severity of viral myocarditis in mice. | Q50656639 | ||
| A role for CCR9 in T lymphocyte development and migration. | Q52545510 | ||
| The mechanically activated p38/MMP-2 signaling pathway promotes bone marrow mesenchymal stem cell migration in rats. | Q52798190 | ||
| Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid protein precursor of Alzheimer's disease. | Q53319618 | ||
| Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. | Q53579885 | ||
| MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. | Q53856850 | ||
| Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. | Q54019102 | ||
| C-terminal truncation of IFN-γ inhibits proinflammatory macrophage responses and is deficient in autoimmune disease. | Q55382749 | ||
| Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. | Q55474490 | ||
| Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor | Q56943427 | ||
| How do cytotoxic lymphocytes kill their targets? | Q57720900 | ||
| Processing of tumour necrosis factor-α precursor by metalloproteinases | Q59059630 | ||
| Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta | Q73366344 | ||
| Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis | Q81390737 | ||
| The matrix metalloproteinase stromelysin-3 cleaves laminin receptor at two distinct sites between the transmembrane domain and laminin binding sequence within the extracellular domain | Q81550469 | ||
| MT1-MMP modulates the mechanosensitivity of osteocytes | Q83143442 | ||
| Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease? | Q87891417 | ||
| Cytokine-mediated communication: a quantitative appraisal of immune complexity | Q91637367 | ||
| Degradomics of matrix metalloproteinases in inflammatory diseases | Q95816218 | ||
| Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways | Q22009006 | ||
| Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor cells and leukocytes reveals NH2-terminal heterogeneity. Functional comparison of different natural isoforms | Q22009107 | ||
| APP binds DR6 to trigger axon pruning and neuron death via distinct caspases | Q22251088 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B | Q24312103 | ||
| Functional analysis of the posttranslational modifications of the death receptor 6 | Q24321317 | ||
| Enzymatic processing of beta-dystroglycan recombinant ectodomain by MMP-9: identification of the main cleavage site | Q24323201 | ||
| Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis | Q24610450 | ||
| An overview of the intrathymic intricacies of T cell development | Q26862512 | ||
| Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential | Q27676429 | ||
| CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells | Q28084610 | ||
| Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3 | Q28144040 | ||
| Role for CCR7 ligands in the emigration of newly generated T lymphocytes from the neonatal thymus | Q28204211 | ||
| The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs | Q28215674 | ||
| Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor | Q28219045 | ||
| A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes | Q28237565 | ||
| CD44 is the principal cell surface receptor for hyaluronate | Q28261336 | ||
| The ephrins and Eph receptors in neural development | Q28266706 | ||
| Eph/ephrin signalling during development | Q28277802 | ||
| Identification and functional characterization of DR6, a novel death domain-containing TNF receptor | Q28280342 | ||
| Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx | Q28288712 | ||
| The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin | Q28474925 | ||
| The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3) | Q28565188 | ||
| Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release | Q28611028 | ||
| Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases | Q28611036 | ||
| A new transcriptional role for matrix metalloproteinase-12 in antiviral immunity | Q28910180 | ||
| Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 | Q29622852 | ||
| Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics | Q30387118 | ||
| Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1. | Q37486259 | ||
| Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting | Q37641731 | ||
| Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases. | Q37784801 | ||
| Mechanisms of T cell development and transformation. | Q37899181 | ||
| Metalloproteinases and their natural inhibitors in inflammation and immunity. | Q38130854 | ||
| Chemokines and chemokine receptors: positioning cells for host defense and immunity | Q38198156 | ||
| Is there new hope for therapeutic matrix metalloproteinase inhibition? | Q38265674 | ||
| GPCR Dynamics: Structures in Motion | Q38953232 | ||
| CD44: More than a mere stem cell marker. | Q38957873 | ||
| Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality. | Q39298374 | ||
| Biochemical analysis of matrix metalloproteinase activation of chemokines CCL15 and CCL23 and increased glycosaminoglycan binding of CCL16. | Q39432022 | ||
| Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activity | Q39890288 | ||
| Tumor necrosis factor receptor superfamily member 21: TNFR-related death receptor-6, DR6. | Q39946611 | ||
| Role of the hemopexin domain of matrix metalloproteinases in cell migration | Q39959867 | ||
| Tumor-derived death receptor 6 modulates dendritic cell development | Q40061758 | ||
| Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration | Q40115388 | ||
| Caspase-1-dependent processing of pro-interleukin-1beta is cytosolic and precedes cell death | Q40173865 | ||
| Proteolytic activation of alternative CCR1 ligands in inflammation | Q40419745 | ||
| PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. | Q40459317 | ||
| Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis | Q40516467 | ||
| Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. | Q40585451 | ||
| Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. | Q40590824 | ||
| Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis | Q40704627 | ||
| Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo | Q40714466 | ||
| Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption | Q40716553 | ||
| Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration | Q40802553 | ||
| Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. | Q41005189 | ||
| Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein | Q41151470 | ||
| Degradation of interleukin 1beta by matrix metalloproteinases. | Q41190792 | ||
| CD44: structure, function, and association with the malignant process. | Q41438683 | ||
| Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells | Q41558819 | ||
| Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration | Q41573564 | ||
| Furin Functions as a Nonproteolytic Chaperone for Matrix Metalloproteinase-28: MMP-28 Propeptide Sequence Requirement | Q41679116 | ||
| Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates | Q33202468 | ||
| Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases | Q33237788 | ||
| Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ | Q33247376 | ||
| MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages | Q33396615 | ||
| Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. | Q33900860 | ||
| CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow | Q33968069 | ||
| Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities | Q34172720 | ||
| Tumor necrosis factor signaling. | Q34185821 | ||
| Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. | Q34226948 | ||
| Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion | Q34230386 | ||
| Role of matrix metalloproteinase-9 dimers in cell migration: design of inhibitory peptides | Q34285372 | ||
| Does CD95 have tumor promoting activities? | Q34557850 | ||
| MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. | Q34598008 | ||
| Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation | Q34665150 | ||
| Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. | Q34942166 | ||
| Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9 | Q35112695 | ||
| Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration. | Q35313033 | ||
| Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy | Q35474102 | ||
| ProMMP-2: TIMP-1 complexes identified in plasma of healthy individuals | Q35778090 | ||
| Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis. | Q36322931 | ||
| Metalloproteinase-mediated release of human Fas ligand | Q36365559 | ||
| Fas/CD95 death receptor and lipid rafts: new targets for apoptosis-directed cancer therapy. | Q36474432 | ||
| Cleavage of myelin associated glycoprotein by matrix metalloproteinases | Q36513220 | ||
| Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis | Q36518598 | ||
| Matrix metalloproteases and PAR1 activation | Q36542806 | ||
| Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I. | Q36629274 | ||
| IL-1β promotes corneal epithelial cell migration by increasing MMP-9 expression through NF-κB- and AP-1-dependent pathways | Q36665694 | ||
| Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. | Q36836612 | ||
| MMP-7 cleaves the NR1 NMDA receptor subunit and modifies NMDA receptor function | Q36950980 | ||
| Matrix metalloproteinase 13 modulates intestinal epithelial barrier integrity in inflammatory diseases by activating TNF. | Q37040818 | ||
| Relationships between glycosaminoglycan and receptor binding sites in chemokines-the CXCL12 example. | Q37107623 | ||
| Metalloproteinase- and gamma-secretase-mediated cleavage of protein-tyrosine phosphatase receptor type Z | Q37142719 | ||
| Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact | Q37348262 | ||
| Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock | Q37444400 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 16 | |
| P921 | main subject | social media | Q202833 |
| P577 | publication date | 2019-08-07 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Matrix Metalloproteases as Influencers of the Cells' Social Media | |
| P478 | volume | 20 |
| Q91646232 | Intracellular Localization in Zebrafish Muscle and Conserved Sequence Features Suggest Roles for Gelatinase A Moonlighting in Sarcomere Maintenance |
| Q89550740 | Matrix Metalloproteinase 13 Activity is Required for Normal and Hypoxia-Induced Precocious Hatching in Zebrafish Embryos |
| Q89660177 | Matrix Metalloproteinases in Diabetic Kidney Disease |
| Q98159046 | Overexpression of B7-H4 promotes renal cell carcinoma progression by recruiting tumor-associated neutrophils via upregulation of CXCL8 |
| Q99571028 | The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity |
| Q98227874 | The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis |
Search more.